Artivion (AORT) announced data from the AMDS PERSEVERE clinical trial was presented in a Late-Breaking Science presentation at the 61st Annual ...

TIkTok sensation based in the US, Naana Donkor Arthur aka NDA has announced the death of Afriyie, a kidney failure victim who ...

H.C. Wainwright reiterated its Buy rating and $7.50 price target for Akebia Therapeutics (NASDAQ:AKBA) stock, which is currently trading near its 52-week high of $2.48 and has shown remarkable ...

For the almost 520,000 Americans who will undergo treatment this year, the process leaves little room for a full life. An ...

Following an "early" time-restricted intermittent fasting pattern is more beneficial for improved blood sugar regulation, and ...

Study finds daratumumab and tocilizumab effective in treating late antibody-mediated rejection after kidney transplant, ...

The firm will pay $45 million upfront for several new targeted agents that it plans to pair with isotopes to develop both ...

That was horrific. The sepsis had a real impact on his kidney. "Initially we were told that we were looking at the kidney transplant and dialysis in his late teens or early twenties, but he's ...

Robot-assisted kidney transplantation from living donors is safe and offers excellent long-term functional outcomes.

(RTTNews) - Verastem Oncology (VSTM) said it has exercised early the option to license from GenFleet Therapeutics VS-7375, a potential best-in-class oral and selective KRAS G12D inhibitor.